Article
Twenty-five percent of the population in the United States is under the age of 14. What’s more, one-quarter of these children have some type of visual need.
Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease
Commercial real estate and your practice, part two with Colin Carr
Study explores the true costs of treating pediatric cataracts
Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
Cerebral visual impairment: A growing concern in pediatric vision loss
Factors affecting ROP development in the 8 weeks following birth